Health Tip: Understanding Autoimmune Disorders - CBC News
February 14, 2007| Health Tip: Understanding Autoimmune Disorders CBC News, Canada - Common autoimmune diseases include type 1 diabetes, rheumatoid arthritis, lupus, multiple sclerosis, Grave's disease and Celiac disease. ... |
Health Tip: Understanding Autoimmune Disorders - Atlanta Journal Constitution (subscription)
February 14, 2007| Health Tip: Understanding Autoimmune Disorders Atlanta Journal Constitution (subscription), GA - Common autoimmune diseases include type 1 diabetes, rheumatoid arthritis, lupus, multiple sclerosis, Grave's disease and Celiac disease. ... |
Nitec Pharma Signs German Marketing Rights for Lodotra to Merck ... - PharmaLive.com (press release)
February 14, 2007| Nitec Pharma Signs German Marketing Rights for Lodotra to Merck ... PharmaLive.com (press release), PA - "Lodotra is a treatment that offers tangible benefit to sufferers of Rheumatoid Arthritis, an indication that Merck has a long commitment to." ... |
Switching TNF-alpha blockers can be effective for rheumatoid ... - Therapeutics Daily (subscription) (press release)
February 14, 2007| Switching TNF-alpha blockers can be effective for rheumatoid ... Therapeutics Daily (subscription) (press release), PA - NEW YORK (Reuters Health) - If patients with rheumatoid arthritis are unable to tolerate or fail to respond to one anti-tumor necrosis factor (TNF)-alpha ... |
Twin Cities / Drug sales reps sue over firing - Therapeutics Daily (subscription) (press release)
February 14, 2007| Twin Cities / Drug sales reps sue over firing Therapeutics Daily (subscription) (press release), PA - ... a drug manufacturer, are claiming they were fired for criticizing the company's marketing of Remicade, a potent treatment for rheumatoid arthritis. ... |
Rigel Announces Initiation of Phase 1 Study Evaluating R763 in ... - PipelineReview.com (press release)
February 14, 2007| Rigel Announces Initiation of Phase 1 Study Evaluating R763 in ... PipelineReview.com (press release), Spain - We have product development programs in inflammatory/autoimmune diseases such as rheumatoid arthritis, thrombocytopenia, and asthma and allergy, ... |
GlaxoSmithKline and Human Genome Sciences announce initiation of ... - PipelineReview.com (press release)
February 14, 2007| GlaxoSmithKline and Human Genome Sciences announce initiation of ... PipelineReview.com (press release), Spain - In lupus, rheumatoid arthritis, and certain other autoimmune diseases, elevated levels of BLyS are believed to contribute to the production of ... |
Twin Cities / Drug sales reps sue over firing - Pioneer Press
February 14, 2007| Twin Cities / Drug sales reps sue over firing Pioneer Press, MN - Remicade is an intravenous solution first approved in 1998 for treatment of Crohn's disease. It was approved by the FDA for rheumatoid arthritis a year ... |
Human Genome Sciences and GlaxoSmithKline Announce Initiation of ... - PR Newswire (press release)
February 14, 2007| Human Genome Sciences and GlaxoSmithKline Announce Initiation of ... PR Newswire (press release), NY - In lupus, rheumatoid arthritis, and certain other autoimmune diseases, elevated levels of BLyS are believed to contribute to the production of ... New hope for lupus patients |
Rigel Announces Initiation Of Phase 1 Study Evaluating R763 In ... - Medical News Today (press release)
February 14, 2007| Rigel Announces Initiation Of Phase 1 Study Evaluating R763 In ... Medical News Today (press release), UK - We have product development programs in inflammatory/autoimmune diseases such as rheumatoid arthritis, thrombocytopenia, and asthma and allergy, ... |
Human Genome Sciences And GlaxoSmithKline Announce Initiation Of ... - Medical News Today (press release)
February 14, 2007| Human Genome Sciences And GlaxoSmithKline Announce Initiation Of ... Medical News Today (press release), UK - In lupus, rheumatoid arthritis, and certain other autoimmune diseases, elevated levels of BLyS are believed to contribute to the production of ... |